Fortress Biotech
FBIO
#10136
Rank
C$96.97 M
Marketcap
C$2.91
Share price
-0.49%
Change (1 day)
-31.68%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): C$0.20 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are C$68.46 Million. In 2025 the company made an earning of -C$48.05 Million, an increase over its 2024 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.20 B-522.45%
2025 -C$48.05 Million-72.02%
2024 -C$0.18 Billion-21.6%
2023 -C$0.22 Billion-28.03%
2022 -C$0.31 Billion29.88%
2021 -C$0.24 Billion59.8%
2020 -C$0.15 Billion1.17%
2019 -C$0.15 Billion-19.84%
2018 -C$0.19 Billion28.99%
2017 -C$0.15 Billion37.92%
2016 -C$0.11 Billion32.31%
2015 -C$76.81 Million164.31%
2014 -C$29.06 Million-45.14%
2013 -C$52.97 Million37.55%
2012 -C$38.51 Million-22.91%
2011 -C$49.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
C$0.16 B-20.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-180.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-C$48.5 Million-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-C$48.31 Million-123.23%๐Ÿ‡บ๐Ÿ‡ธ USA